X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17307) 17307
Book Review (2113) 2113
Newsletter (2023) 2023
Newspaper Article (1564) 1564
Publication (1245) 1245
Book Chapter (79) 79
Conference Proceeding (68) 68
Dissertation (32) 32
Trade Publication Article (31) 31
Magazine Article (26) 26
Web Resource (25) 25
Book / eBook (22) 22
Government Document (3) 3
Reference (3) 3
Presentation (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13863) 13863
neuroblastoma (13091) 13091
humans (12727) 12727
oncology (5752) 5752
female (4734) 4734
cancer (4597) 4597
male (4508) 4508
animals (4085) 4085
neuroblastoma - pathology (3948) 3948
child (3813) 3813
child, preschool (3341) 3341
cell line, tumor (3261) 3261
neuroblastoma - drug therapy (3176) 3176
infant (3076) 3076
apoptosis (2855) 2855
pediatrics (2848) 2848
tumors (2720) 2720
mice (2681) 2681
research (2650) 2650
chemotherapy (2152) 2152
neuroblastoma - therapy (2111) 2111
neuroblastoma - metabolism (2024) 2024
adolescent (1910) 1910
prognosis (1894) 1894
expression (1871) 1871
neuroblastoma - genetics (1786) 1786
children (1627) 1627
care and treatment (1625) 1625
proteins (1419) 1419
adult (1379) 1379
biochemistry & molecular biology (1368) 1368
neurosciences (1362) 1362
cell biology (1340) 1340
gene expression (1335) 1335
analysis (1330) 1330
apoptosis - drug effects (1262) 1262
health aspects (1242) 1242
cancer therapies (1231) 1231
surgery (1221) 1221
tumor cells, cultured (1207) 1207
therapy (1147) 1147
metastasis (1118) 1118
hematology (1089) 1089
genetic aspects (1014) 1014
abridged index medicus (998) 998
neuroblastoma - diagnosis (969) 969
combined modality therapy (964) 964
neoplasm staging (950) 950
reports (942) 942
pharmacology & pharmacy (941) 941
treatment outcome (930) 930
infant, newborn (926) 926
immunotherapy (912) 912
antineoplastic agents - pharmacology (907) 907
article (893) 893
cells (893) 893
medical research (884) 884
antineoplastic combined chemotherapy protocols - therapeutic use (883) 883
medicine (883) 883
cell survival - drug effects (878) 878
oxidative stress (868) 868
neuroblastoma-cells (861) 861
differentiation (807) 807
diagnosis (800) 800
kinases (796) 796
dose-response relationship, drug (794) 794
antineoplastic agents - therapeutic use (786) 786
research article (786) 786
neuroblastoma - surgery (772) 772
neuroblastoma - mortality (750) 750
rats (731) 731
middle aged (727) 727
retrospective studies (723) 723
in-vitro (721) 721
survival (719) 719
growth (710) 710
neuroblastoma - radiotherapy (701) 701
drugs (684) 684
multidisciplinary sciences (684) 684
high-risk neuroblastoma (675) 675
biology (670) 670
activation (669) 669
development and progression (668) 668
signal transduction (667) 667
physiological aspects (666) 666
time factors (665) 665
mutation (663) 663
universities and colleges (652) 652
patients (640) 640
risk factors (640) 640
stem cells (637) 637
cell proliferation - drug effects (632) 632
mice, nude (626) 626
pathology (624) 624
cell cycle (621) 621
cytotoxicity (620) 620
neurons (615) 615
gene expression regulation, neoplastic (614) 614
medicine & public health (614) 614
neuro-blastoma (614) 614
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20237) 20237
German (211) 211
French (168) 168
Japanese (146) 146
Italian (69) 69
Spanish (58) 58
Polish (53) 53
Russian (52) 52
Chinese (39) 39
Czech (9) 9
Dutch (8) 8
Danish (7) 7
Turkish (7) 7
Korean (6) 6
Swedish (6) 6
Hungarian (5) 5
Norwegian (5) 5
Hebrew (3) 3
Romanian (3) 3
Serbian (2) 2
Catalan (1) 1
Croatian (1) 1
Finnish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2010, Volume 363, Issue 14, pp. 1324 - 1334
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 09/2015, Volume 62, Issue 9, pp. 1529 - 1535
BackgroundThe value of gross total resection (GTR) for children with high-risk neuroblastoma (NB) is controversial. We hypothesized that patients undergoing... 
neuroblastoma | BMT for malignant conditions | Surgery | sickle cell | Neuroblastoma | Sickle cell | DIAGNOSIS | 13-CIS-RETINOIC ACID | II NEUROBLASTOMA | CHEMOTHERAPY | IMPACT | THERAPY | ONCOLOGY | PEDIATRICS | RADIOTHERAPY | GROSS TOTAL RESECTION | HEMATOLOGY | AGE | Adrenal Gland Neoplasms - surgery | Adrenal Gland Neoplasms - drug therapy | Retroperitoneal Neoplasms - epidemiology | Humans | Retroperitoneal Neoplasms - therapy | Child, Preschool | Infant | Male | Risk | Transplantation, Autologous | Neuroblastoma - therapy | Mediastinal Neoplasms - drug therapy | Adrenal Gland Neoplasms - epidemiology | Neuroblastoma - secondary | Retroperitoneal Neoplasms - drug therapy | Mediastinal Neoplasms - therapy | Female | Neoadjuvant Therapy | Neuroblastoma - epidemiology | Retrospective Studies | Radiotherapy, Adjuvant | Retroperitoneal Neoplasms - surgery | Mediastinal Neoplasms - surgery | Mediastinal Neoplasms - epidemiology | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Combined Modality Therapy | Adrenalectomy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neuroblastoma - drug therapy | Selection Bias | Neuroblastoma - surgery | Transplantation Conditioning | Peripheral Blood Stem Cell Transplantation | Adrenal Gland Neoplasms - therapy | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 1015 - 1022
Purpose To report the early outcomes for children with high-risk neuroblastoma treated with proton radiotherapy (RT) and to compare the dose distributions for... 
Radiology | Hematology, Oncology and Palliative Medicine | High-risk neuroblastoma | IMPT | Intensity-modulated radiotherapy | Proton radiotherapy | IMRT | Intensity-modulated proton radiotherapy | SURVIVAL | RADIATION-THERAPY | TRANSPLANTATION | IMPACT | ONCOLOGY | INFANTS | LOCAL-CONTROL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RESEARCH-HOSPITAL EXPERIENCE | Protons - adverse effects | Humans | Child, Preschool | Protons - therapeutic use | Infant | Male | Neuroblastoma - therapy | Organs at Risk | Radiotherapy, Intensity-Modulated - adverse effects | Neoplasm, Residual | Organ Sparing Treatments - methods | Female | Neuroblastoma - pathology | Radiotherapy Dosage | Neuroblastoma - genetics | Radiotherapy, Intensity-Modulated - methods | Induction Chemotherapy - methods | Neuroblastoma - diagnostic imaging | Treatment Outcome | Tumor Burden | Combined Modality Therapy - adverse effects | Photons - therapeutic use | Radiography | Neuroblastoma - radiotherapy | Radiotherapy, Conformal - adverse effects | Combined Modality Therapy - methods | Radiotherapy, Conformal - methods | Pediatrics | Neuroblastoma | Radiotherapy | Nuclear radiation | Analysis | Radiation | Index Medicus | Adjuvants | SURGERY | PATIENTS | NEOPLASMS | FAILURES | LUNGS | ERYTHEMA | RADIATION DOSES | PROTONS | CHEMOTHERAPY | CHILDREN | HEART | KIDNEYS | RADIATION DOSE DISTRIBUTIONS | RADIOLOGY AND NUCLEAR MEDICINE | PEDIATRICS | STEM CELLS | RADIOTHERAPY | SKIN | SIDE EFFECTS | ANOREXIA | HAZARDS
Journal Article
Current opinion in pediatrics, ISSN 1040-8703, 02/2019, Volume 31, Issue 1, pp. 14 - 20
Purpose of review Our understanding of the biologic basis of neuroblastoma, the genetic heterogeneity of this malignancy and the role of host factors has... 
targeted therapy | NATURAL-KILLER-CELLS | risk classification | neuroblastoma | predisposition | OPEN-LABEL | CHEMOTHERAPY | RADIATION-THERAPY | CHILDREN | ANTI-GD2 MONOCLONAL-ANTIBODY | COPY-NUMBER | immunotherapy | PEDIATRICS | LOCAL-CONTROL | HIGH-RISK NEUROBLASTOMA | SEQUENCING REVEALS | Care and treatment | Forecasts and trends | Neuroblastoma | Risk factors | Methods | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 3, pp. e151 - e155
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 67, pp. 130 - 140
Abstract Objectives Dose-finding trials are fundamental to develop novel drugs for children and adolescents with advanced cancer. It is crucial to maximise... 
Hematology, Oncology and Palliative Medicine | Innovative Therapies for Children with Cancer | Dose-finding trial | Prognostic factor | Phase I trial | Children | Adolescents | Survival | ONCOLOGY TRIALS | SCORE | VALIDATION | I CLINICAL-TRIALS | CONTEXT | PEDIATRIC PHASE-I | CENTER EXPERIENCE | ONCOLOGY | Osteosarcoma - drug therapy | Multivariate Analysis | Prognosis | Neuroectodermal Tumors, Primitive - drug therapy | Humans | Child, Preschool | Infant | Male | Neuroblastoma - mortality | Sarcoma, Ewing - mortality | Medulloblastoma - mortality | Ependymoma - drug therapy | Employment | Ependymoma - mortality | Sarcoma - mortality | Female | Rhabdomyosarcoma - drug therapy | Retrospective Studies | Child | Rhabdomyosarcoma - mortality | Schools | Osteosarcoma - mortality | Glioma - mortality | Neuroectodermal Tumors, Primitive - mortality | Europe | Proportional Hazards Models | Neoplasms - mortality | Therapies, Investigational | Survival Rate | Sarcoma - drug therapy | Neoplasms - drug therapy | Sarcoma, Ewing - drug therapy | Neuroblastoma - drug therapy | Adolescent | Medulloblastoma - drug therapy | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Clinical Trials, Phase I as Topic | Glioma - drug therapy | Care and treatment | Patient outcomes | Children's hospitals | Oncology, Experimental | Clinical trials | Research | Health aspects | Cancer | Index Medicus
Journal Article
CURRENT TOPICS IN MEDICINAL CHEMISTRY, ISSN 1568-0266, 10/2013, Volume 13, Issue 19, pp. 2465 - 2476
In the last two decades, knowledge of the neurobiology of prion diseases or transmissible spongiform encephalopathies (TSE) has significantly advanced, but a... 
presymtomatic treatment | ANTI-PRP ANTIBODIES | CHEMISTRY, MEDICINAL | INFECTED NEUROBLASTOMA-CELLS | oligomers | ALZHEIMERS-DISEASE | Clinical trials | AMPHOTERICIN-B | CONGO-RED | IN-VITRO | prion diseases | immunotherapy | WILD-TYPE MICE | therapeutic targets | CREUTZFELDT-JAKOB-DISEASE | TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES | prion protein | AMYLOID-BETA OLIGOMERS
Journal Article
Journal Article
Cancer Cell, ISSN 1535-6108, 11/2014, Volume 26, Issue 5, pp. 682 - 694
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2012, Volume 18, Issue 11, pp. 1699 - 1704
Anaplastic large cell lymphoma (ALCL) is an aggressive non-Hodgkin's lymphoma found in children and young adults. ALCLs frequently carry a chromosomal... 
MEDICINE, RESEARCH & EXPERIMENTAL | FUSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | NEUROBLASTOMA | LARGE-CELL LYMPHOMA | CELL BIOLOGY | LUNG-CANCER | INHIBITION | GENE | HODGKIN LYMPHOMA | C-JUN | ACTIVATING MUTATIONS | Piperazines - administration & dosage | Translocation, Genetic | Protein-Tyrosine Kinases - metabolism | Transcription Factor AP-1 - genetics | Humans | Molecular Targeted Therapy | Receptor, Platelet-Derived Growth Factor beta - genetics | Transcription Factor AP-1 - metabolism | Stem Cell Transplantation | Protein-Tyrosine Kinases - genetics | Receptor, Platelet-Derived Growth Factor beta - antagonists & inhibitors | Receptor, Platelet-Derived Growth Factor alpha - antagonists & inhibitors | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Oncogene Protein p65(gag-jun) - genetics | Gene Expression Regulation, Neoplastic - drug effects | Nuclear Proteins - genetics | Lymphoma, Large-Cell, Anaplastic - metabolism | Receptor, Platelet-Derived Growth Factor beta - metabolism | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Pyrimidines - administration & dosage | Mice, Transgenic | Nuclear Proteins - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Imatinib Mesylate | Remission Induction | Animals | Receptor Protein-Tyrosine Kinases - genetics | Receptor, Platelet-Derived Growth Factor alpha - genetics | Lymphoma, Large-Cell, Anaplastic - drug therapy | Cell Line, Tumor | Lymphoma, Large-Cell, Anaplastic - pathology | Mice | Benzamides | Neoplasm Staging | Oncogene Protein p65(gag-jun) - metabolism | Receptors | Blood platelets | Physiological aspects | Genetic aspects | Non-Hodgkin's lymphomas | Research | Drug therapy | Protein kinases | Therapy | Lymphomas | Cells | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2007, Volume 25, Issue 9, pp. 1054 - 1060
Journal Article